Search

Displaying results 6101 - 6110 of 10000 in total
  1. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C). … It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK.

  2. Drug

    Tavaborole

    go.drugbank.com/drugs/DB09041
    Approved

    Tavaborale is a novel, boron-based topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed due to *Trichophyton rubrum* or *Trichophyton mentagrophytes … Tavaborole functions by inhibiting Leucyl-tRNA synthetase, or LeuRS, an essential fungal enzyme required for protein synthesis and for the catalysis of ATP-dependent ligation of L-leucine to tRNA(Leu).

  3. Drug

    Flovagatran

    go.drugbank.com/drugs/DB05714
    Experimental

  4. Drug

    Thrombopoietin

    go.drugbank.com/drugs/DB06534
    Investigational

  5. Drug

    Estradiol sulfamate

    go.drugbank.com/drugs/DB06597
    Investigational

  6. Drug

    Ilepatril

    go.drugbank.com/drugs/DB06604
    Investigational

  7. Drug

    Clazosentan

    go.drugbank.com/drugs/DB06677
    Investigational

    Categories: Receptor, Endothelin A
  8. Drug

    Viquidacin

    go.drugbank.com/drugs/DB19549
    Experimental

    Viquidacin is a small molecule drug. The usage of the INN stem '-dacin' in the name indicates that Viquidacin is a antibiotic, DNA gyrase and topoisomerase IV inhibitor. … Viquidacin has a monoisotopic molecular weight of 504.16 Da.

    Categories: Streptogramin Group A
  9. Drug

    Abitesartan

    go.drugbank.com/drugs/DB19863
    Experimental

    Abitesartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Abitesartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). … Abitesartan has a monoisotopic molecular weight of 461.24 Da.

  10. Drug

    ADL 10-0101

    go.drugbank.com/drugs/DB05443
    Experimental

    ADL 10-0101 is a peripheral kappa opioid agonist analgesic product candidate. … Because ADL 10-0101 does not cross the blood-brain barrier and enter the brain when administered at therapeutic doses, it is expected to avoid central nervous system side effects.